THE CHROMOSOME | Clinical Content Series
Insulin Resistance
Back to Case Studies ArchiveCase Study
She came in carrying 34 extra kilograms and a decade of being told she lacked discipline. She had done everything right, or rather, everything she had been told was right. She had counted calories. She had walked every morning. She had seen three doctors before me, each of whom had handed her a diet sheet and sent her home.
When she sat across from me I did not ask her what she was eating. I asked her what her body was doing with what she was eating. That is an entirely different question. And it is the question that changes everything.
Her fasting insulin was almost three times the upper limit of normal. Her metabolic picture was one I had seen many times in Pakistani patients, the weight that would not move, the fatigue that no sleep fixed, the hunger that never fully disappeared. Her body was producing insulin perfectly. The problem was that her cells had stopped listening to it. Every meal she ate was being met with a hormonal instruction her body could no longer follow. The glucose had nowhere to go. So it was stored. As fat. Around her organs. Deeper than any diet could reach.
This is what I have observed consistently in Pakistani patients: the FTO gene's influence does not announce itself on a laboratory form. It announces itself in the clinical picture. In the pattern of weight gain. In the distribution of fat. In the way the body responds, or refuses to respond, to every conventional intervention. You do not need a genetic test to know that your biology is working against you. You need a physician who knows what to look for.
This was not a failure of willpower. This was insulin resistance, and in her case it was not a complication of her obesity. It was the cause of it. We did not begin with a diet. We began with her biology. Eighteen months later she had lost 27 kilograms. Her fasting insulin was normal for the first time in a decade.
That is what treating the cause looks like.
FAQs
Insulin resistance occurs when the body's cells stop responding to insulin, forcing the pancreas to overproduce it. That excess insulin drives fat storage, particularly visceral fat around the organs. Pakistanis are disproportionately vulnerable because the FTO gene variant prevalent in our population alters energy regulation, appetite signalling, and fat distribution from the ground up. Research from Lahore and Karachi confirms that Pakistanis develop insulin resistance at lower body weights than Western populations. Dr. Zaar's Chromosome 16q12.2 Recalibration Model was the first clinical framework in Pakistan built specifically around this predisposition.
High circulating insulin is one of the most powerful fat storage signals in the human body. It directs every available calorie into fat cells while simultaneously blocking the release of stored fat for energy. The result is a biological trap, the patient eats less, feels exhausted, and still gains weight. No calorie restricted diet breaks this cycle because the cycle is hormonal, not caloric. THE CHROMOSOME protocol treats the insulin pathway directly, which is the only intervention that actually works.
The FTO gene at position 16q12.2 on Chromosome 16 impairs mitochondrial function in muscle tissue, where insulin mediated glucose uptake should occur. When muscles cannot absorb glucose efficiently, insulin resistance follows. In Pakistanis this genetic predisposition is significantly more prevalent than in European populations and is amplified by visceral fat accumulation, chronic inflammation, and dietary patterns. Dr. Zaar identifies this predisposition through clinical and metabolic assessment, no genetic laboratory test is required.
Yes, but only when its biological drivers are addressed directly. Reducing circulating insulin requires targeted dietary recalibration, peptide based interventions where indicated, restoration of mitochondrial function, and reduction of visceral fat. Eating less alone achieves none of these. In THE CHROMOSOME protocol, reversal of insulin resistance is a milestone, not the destination. The destination is complete hormonal restoration, rebuilding the environment that created the resistance in the first place.
Excess insulin stimulates the ovaries to overproduce testosterone and other androgens, disrupting ovulation and driving PCOS. In Pakistani women, the FTO gene's influence accelerates this process, insulin sensitivity declines earlier, and androgen excess begins years before weight becomes clinically significant. By the time a Pakistani woman presents with obesity, the PCOS is usually well established. THE CHROMOSOME protocol treats insulin resistance and PCOS as one unified biological event, not two separate diagnoses.
Visceral fat is not passive storage. It is an active endocrine organ that continuously releases inflammatory cytokines and adipokines into the bloodstream, directly interfering with insulin receptor function at the cellular level. The liver, bathed in this inflammatory environment, becomes insulin resistant itself and begins overproducing glucose even during fasting. Dr. Zaar's Visceral Hormonal Storm Model identifies this process as the engine of metabolic disease in Pakistani patients, where visceral fat accumulates at lower body weight thresholds than Western norms.
Because they were built around a caloric model that does not apply to insulin resistant patients. Restricting calories when circulating insulin is high does not unlock stored fat, it slows the metabolism, intensifies hunger, and accelerates muscle loss. The weight returns the moment normal eating resumes. THE CHROMOSOME protocol begins where every other programme ends, at the hormonal and genetic level that conventional medicine in Pakistan has never examined.
Chronic stress keeps cortisol persistently elevated, which raises blood glucose continuously and drives the pancreas to produce more insulin. Over time, this sustained insulin demand creates resistance. Pakistani patients carry a particular cortisol burden shaped by social, familial, and economic pressures that Western clinical models ignore entirely. The FTO gene amplifies this response, meaning Pakistani patients experience a deeper metabolic consequence from the same level of stress. THE CHROMOSOME protocol includes a full cortisol and psychological assessment as a core diagnostic component.